DANAHER CORP (DHR) Stock Price, Quote, News and Overview
NYSE:DHR - New York Stock Exchange, Inc. - US2358511028 - Common Stock - Currency: USD
DHR Quote, Performance and Key Statistics
187.82
-8.79 (-4.47%)
The current stock price of DHR is 187.82 USD. In the past month the price decreased by -1.11%. In the past year, price decreased by -29.34%.
DHR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 18.54 | 153.28B | ||
| A | AGILENT TECHNOLOGIES INC | 21 | 31.79B | ||
| IQV | IQVIA HOLDINGS INC | 12.55 | 25.01B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.63 | 23.30B | ||
| WAT | WATERS CORP | 29 | 20.55B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.13 | 14.85B | ||
| ILMN | ILLUMINA INC | 23.49 | 12.38B | ||
| TEM | TEMPUS AI INC | N/A | 11.21B | ||
| RVTY | REVVITY INC | 18.46 | 10.94B | ||
| ICLR | ICON PLC | 9.64 | 10.92B | ||
| QGEN | QIAGEN N.V. | 17.89 | 8.89B | ||
| AVTR | AVANTOR INC | 12.72 | 8.76B |
Related stock screener links
About DHR
Company Profile
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company Info
DANAHER CORP
2200 Pennsylvania Ave NW Ste 800W
WASHINGTON WASHINGTON DC 20037 US
CEO: Rainer M. Blair
Employees: 62000
Phone: 12028280850
DANAHER CORP / DHR FAQ
What is the stock price of DANAHER CORP today?
The current stock price of DHR is 187.82 USD. The price decreased by -4.47% in the last trading session.
What is the ticker symbol for DANAHER CORP stock?
The exchange symbol of DANAHER CORP is DHR and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is DHR stock listed?
DHR stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for DANAHER CORP stock?
32 analysts have analysed DHR and the average price target is 248.28 USD. This implies a price increase of 32.19% is expected in the next year compared to the current price of 187.82. Check the DANAHER CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DANAHER CORP worth?
DANAHER CORP (DHR) has a market capitalization of 134.42B USD. This makes DHR a Large Cap stock.
How many employees does DANAHER CORP have?
DANAHER CORP (DHR) currently has 62000 employees.
What are the support and resistance levels for DANAHER CORP (DHR) stock?
DANAHER CORP (DHR) has a resistance level at 199.03. Check the full technical report for a detailed analysis of DHR support and resistance levels.
Is DANAHER CORP (DHR) expected to grow?
The Revenue of DANAHER CORP (DHR) is expected to grow by 3.15% in the next year. Check the estimates tab for more information on the DHR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DANAHER CORP (DHR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DHR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DHR, evaluating the profitability, health, valuation and growth aspects
- DANAHER CORP (DHR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DANAHER CORP (DHR) Sales and EPS estimates to see what analysts future expectations are.
- DANAHER CORP (DHR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DANAHER CORP (DHR) Insider and Institutional Ownership to learn about the owners and their transactions.
- DANAHER CORP (DHR) Stock Chart to make your own analysis
- DANAHER CORP (DHR) Latest news and press-releases to stay up to date.
Does DANAHER CORP (DHR) stock pay dividends?
DANAHER CORP (DHR) has a dividend yield of 0.66%. The yearly dividend amount is currently 1.05. Check the full fundamental report for a detailed analysis of DHR dividend history, reliability and sustainability.
When does DANAHER CORP (DHR) report earnings?
DANAHER CORP (DHR) will report earnings on 2025-07-21, after the market close.
What is the Price/Earnings (PE) ratio of DANAHER CORP (DHR)?
The PE ratio for DANAHER CORP (DHR) is 25.21. This is based on the reported non-GAAP earnings per share of 7.45 and the current share price of 187.82 USD. Check the full fundamental report for a full analysis of the valuation metrics for DHR.
What is the Short Interest ratio of DANAHER CORP (DHR) stock?
The outstanding short interest for DANAHER CORP (DHR) is 1.23% of its float. Check the ownership tab for more information on the DHR short interest.
DHR Technical Analysis
DHR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DHR. While DHR has a great profitability rating, there are some minor concerns on its financial health.
DHR Financial Highlights
Over the last trailing twelve months DHR reported a non-GAAP Earnings per Share(EPS) of 7.45. The EPS decreased by -7.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.81% | ||
| ROA | 4.76% | ||
| ROE | 7.4% | ||
| Debt/Equity | 0.31 |
DHR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to DHR. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 3.51% and a revenue growth 3.15% for DHR